Kraft Davis & Associates LLC Cuts Holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Kraft Davis & Associates LLC lowered its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 4.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 3,497 shares of the company’s stock after selling 161 shares during the quarter. Kraft Davis & Associates LLC’s holdings in Invesco Pharmaceuticals ETF were worth $302,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in PJP. FMR LLC raised its holdings in Invesco Pharmaceuticals ETF by 29.4% in the third quarter. FMR LLC now owns 1,057 shares of the company’s stock valued at $92,000 after acquiring an additional 240 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Invesco Pharmaceuticals ETF by 6.3% during the 4th quarter. JPMorgan Chase & Co. now owns 4,301 shares of the company’s stock worth $355,000 after buying an additional 255 shares during the last quarter. Bank of Montreal Can lifted its holdings in Invesco Pharmaceuticals ETF by 48.7% during the 4th quarter. Bank of Montreal Can now owns 1,044 shares of the company’s stock worth $86,000 after buying an additional 342 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Invesco Pharmaceuticals ETF by 195.7% during the 4th quarter. Jones Financial Companies Lllp now owns 2,176 shares of the company’s stock worth $180,000 after acquiring an additional 1,440 shares in the last quarter. Finally, Joseph Group Capital Management increased its holdings in shares of Invesco Pharmaceuticals ETF by 15.4% in the 4th quarter. Joseph Group Capital Management now owns 17,397 shares of the company’s stock valued at $1,437,000 after acquiring an additional 2,317 shares during the last quarter.

Invesco Pharmaceuticals ETF Stock Down 3.1 %

PJP stock opened at $75.32 on Wednesday. The business has a 50 day moving average price of $84.99 and a 200 day moving average price of $85.31. The stock has a market cap of $228.22 million, a price-to-earnings ratio of 21.82 and a beta of 0.56. Invesco Pharmaceuticals ETF has a fifty-two week low of $74.40 and a fifty-two week high of $89.87.

Invesco Pharmaceuticals ETF Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 24th were given a $0.2729 dividend. This is an increase from Invesco Pharmaceuticals ETF’s previous dividend of $0.21. The ex-dividend date was Monday, March 24th.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.